276 related articles for article (PubMed ID: 31635843)
1. Circulating miRNA analysis for cancer diagnostics and therapy.
Valihrach L; Androvic P; Kubista M
Mol Aspects Med; 2020 Apr; 72():100825. PubMed ID: 31635843
[TBL] [Abstract][Full Text] [Related]
2. Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future?
Lampignano R; Kloten V; Krahn T; Schlange T
Mol Aspects Med; 2020 Apr; 72():100844. PubMed ID: 31959359
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194
[TBL] [Abstract][Full Text] [Related]
4. Droplet Digital PCR for Absolute Quantification of Extracellular MicroRNAs in Plasma and Serum: Quantification of the Cancer Biomarker hsa-miR-141.
Giraldez MD; Chevillet JR; Tewari M
Methods Mol Biol; 2018; 1768():459-474. PubMed ID: 29717459
[TBL] [Abstract][Full Text] [Related]
5. Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs.
Belli R; Ferraro E; Molfino A; Carletti R; Tambaro F; Costelli P; Muscaritoli M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445710
[TBL] [Abstract][Full Text] [Related]
6. Advanced liquid biopsy technologies for circulating biomarker detection.
Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
[TBL] [Abstract][Full Text] [Related]
7. Circulating MicroRNAs as Cancer Biomarkers in Liquid Biopsies.
Suárez B; Solé C; Márquez M; Nanetti F; Lawrie CH
Adv Exp Med Biol; 2022; 1385():23-73. PubMed ID: 36352210
[TBL] [Abstract][Full Text] [Related]
8. CIRCULATING microRNAs: POTENTIAL BIOMARKERS IN CANCER DETECTION, DIAGNOSIS AND PROGNOSIS.
Makarem N; Mourad A; Nassar FJ; Nasr R
J Med Liban; 2016 Aug; 64(2):116-122. PubMed ID: 30452151
[TBL] [Abstract][Full Text] [Related]
9. Emerging isothermal amplification technologies for microRNA biosensing: Applications to liquid biopsies.
Gines G; Menezes R; Xiao W; Rondelez Y; Taly V
Mol Aspects Med; 2020 Apr; 72():100832. PubMed ID: 31767382
[TBL] [Abstract][Full Text] [Related]
10. Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis.
Precazzini F; Detassis S; Imperatori AS; Denti MA; Campomenosi P
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503982
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Distribution Profiles of Circulating MicroRNAs by Asymmetrical Flow Field Flow Fractionation.
Flack K; Jimenez LA; Zhong W
Methods Mol Biol; 2017; 1509():161-168. PubMed ID: 27826926
[TBL] [Abstract][Full Text] [Related]
12. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.
Larrea E; Sole C; Manterola L; Goicoechea I; Armesto M; Arestin M; Caffarel MM; Araujo AM; Araiz M; Fernandez-Mercado M; Lawrie CH
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128908
[TBL] [Abstract][Full Text] [Related]
13. Circulating miRNAs as Biomarkers in Aggressive B Cell Lymphomas.
Drees EEE; Pegtel DM
Trends Cancer; 2020 Nov; 6(11):910-923. PubMed ID: 32660885
[TBL] [Abstract][Full Text] [Related]
14. Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis.
Keller A; Fehlmann T; Backes C; Kern F; Gislefoss R; Langseth H; Rounge TB; Ludwig N; Meese E
RNA Biol; 2020 Oct; 17(10):1416-1426. PubMed ID: 32456538
[TBL] [Abstract][Full Text] [Related]
15. The circulating transcriptome as a source of cancer liquid biopsy biomarkers.
Sole C; Arnaiz E; Manterola L; Otaegui D; Lawrie CH
Semin Cancer Biol; 2019 Oct; 58():100-108. PubMed ID: 30684535
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows.
Kloten V; Neumann MHD; Di Pasquale F; Sprenger-Haussels M; Shaffer JM; Schlumpberger M; Herdean A; Betsou F; Ammerlaan W; Af Hällström T; Serkkola E; Forsman T; Lianidou E; Sjöback R; Kubista M; Bender S; Lampignano R; Krahn T; Schlange T;
Clin Chem; 2019 Sep; 65(9):1132-1140. PubMed ID: 31235535
[TBL] [Abstract][Full Text] [Related]
17. MIQE-Compliant Validation of MicroRNA Biomarker Signatures Established by Small RNA Sequencing.
Mussack V; Hermann S; Buschmann D; Kirchner B; Pfaffl MW
Methods Mol Biol; 2020; 2065():23-38. PubMed ID: 31578685
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers.
Ozawa PMM; Jucoski TS; Vieira E; Carvalho TM; Malheiros D; Ribeiro EMSF
Transl Res; 2020 Sep; 223():40-60. PubMed ID: 32413499
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers.
Takizawa S; Matsuzaki J; Ochiya T
Cancer Biomark; 2022; 35(1):1-9. PubMed ID: 35786647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
